Search Results - Qiwen Fang
- Showing 1 - 2 results of 2
-
1
Hypomethylating agent versus venetoclax combination: an electronic health records-based target trial emulation among Asian elderly patients with newly diagnosed acute myeloid leuka... by Qiwen Fang, Chi Yeung Fung, Jiaqi Wang, Wing Hei Lai, Raymond S. M. Wong, Bonnie C. S. Kho, June S. M. Lau, Vivien W. M. Mak, Chung Yin Ha, Xue Li, Anskar Yu-Hung Leung
Published 2025-07-01Background: The pivotal trial on venetoclax and hypomethylating agents in unfit elderly acute myeloid leukaemia (AML) has got FDA approval. However, Asian patients were under-represented and showed no survival advantage. Objective: We aimed to compare overall survival and healthcare resource utilisa...
Get full text
Article -
2
Epidemiological Analysis of the COVID-19 Clusters in the Early Stages of the Epidemic in Shanghai, China: Pandemic-to-Epidemic Response Shift by Dechuan Kong, Qiwen Fang, Jian Chen, Linjie Hu, Yihan Lu, Yaxu Zheng, Yiyi Zhu, Bihong Jin, Wenjia Xiao, Shenghua Mao, Chenyan Jiang, Xiaohuan Gong, Sheng Lin, Ruobing Han, Xiao Yu, Qi Qiu, Xiaodong Sun, Hao Pan, Huanyu Wu
Published 2025-06-01As COVID-19 transitions from pandemic to endemic, our prevention and control policies have shifted from broad, strict community interventions to focusing on the prevention of cluster outbreaks. Currently, information on the characteristics of cluster outbreaks remains limited. This study describes t...
Get full text
Article